A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor β Receptor Signaling

被引:52
作者
Gu, Ai-Di [1 ,2 ]
Zhang, Song [1 ,2 ]
Wang, Yunqi [1 ,2 ]
Xiong, Hui [1 ,2 ]
Curtis, Thomas A. [1 ,2 ]
Wan, Yisong Y. [1 ,2 ,3 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[3] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China
关键词
TGF-BETA; C-MYC; REQUIREMENTS; INACTIVATION; AUTOIMMUNITY; LYMPHOCYTES; MECHANISMS; EXPRESSION; PLASTICITY; INDUCTION;
D O I
10.1016/j.immuni.2014.12.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transforming growth factor-beta (TGF-beta) suppresses T cell function to maintain self-tolerance and to promote tumor immune evasion. Yet how Smad4, a transcription factor component of TGF-beta signaling, regulates T cell function remains unclear. Here we have demonstrated an essential role for Smad4 in promoting T cell function during autoimmunity and anti-tumor immunity. Smad4 deletion rescued the lethal autoimmunity resulting from transforming growth factor-beta receptor (TGF-beta R) deletion and compromised T-cell-mediated tumor rejection. Although Smad4 was dispensable for T cell generation, homeostasis, and effector function, it was essential for T cell proliferation after activation in vitro and in vivo. The transcription factor Myc was identified to mediate Smad4-controlled T cell proliferation. This study thus reveals a requirement of Smad4 for T-cell-mediated autoimmunity and tumor rejection, which is beyond the current paradigm. It highlights a TGF-beta R-independent role for Smad4 in promoting T cell function, autoimmunity, and anti-tumor immunity.
引用
收藏
页码:68 / 79
页数:12
相关论文
共 47 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]   Signal transduction by the TGF-β superfamily [J].
Attisano, L ;
Wrana, JL .
SCIENCE, 2002, 296 (5573) :1646-1647
[3]   TGFβ:: the molecular Jekyll and Hyde of cancer [J].
Bierie, Brian ;
Moses, Harold L. .
NATURE REVIEWS CANCER, 2006, 6 (07) :506-520
[4]   TGF-β receptor controls B cell responsiveness and induction of IgA in vivo [J].
Cazac, BB ;
Roes, J .
IMMUNITY, 2000, 13 (04) :443-451
[5]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[6]   Differential requirements for Smad4 in TGFβ-dependent patterning of the early mouse embryo [J].
Chu, GC ;
Dunn, NR ;
Anderson, DC ;
Oxburgh, L ;
Robertson, EJ .
DEVELOPMENT, 2004, 131 (15) :3501-3512
[7]   Conditional inactivation of the TGF-β type II receptor using Cre:Lox [J].
Chytil, A ;
Magnuson, MA ;
Wright, CVE ;
Moses, HL .
GENESIS, 2002, 32 (02) :73-75
[8]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[9]   Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: "N1" versus "N2" TAN [J].
Fridlender, Zvi G. ;
Sun, Jing ;
Kim, Samuel ;
Kapoor, Veena ;
Cheng, Guanjun ;
Ling, Leona ;
Worthen, G. Scott ;
Albelda, Steven M. .
CANCER CELL, 2009, 16 (03) :183-194
[10]   Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells [J].
Gorelik, L ;
Flavell, RA .
NATURE MEDICINE, 2001, 7 (10) :1118-1122